Key Role of MicroRNAs in Waldenström's Macroglobulinemia Pathogenesis
- 1 February 2011
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (1), 109-111
- https://doi.org/10.3816/clml.2011.n.022
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1Blood, 2009
- microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemiaBlood, 2009
- The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2Cancer Research, 2009
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in CancerScience, 2008
- PAK Is Regulated by PI3K, PIX, CDC42, and PP2Cα and Mediates Focal Adhesion Turnover in the Hyperosmotic Stress-induced p38 PathwayOnline Journal of Public Health Informatics, 2008
- MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3BProceedings of the National Academy of Sciences of the United States of America, 2007
- BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasThe Journal of Pathology, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammalsNature, 2005
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003